Benzinga | Feb 22, 2021 08:43AM EST

OPKO's BioReference Laboratories To Participate In NY Forward Rapid Testing Program, Opens Eight COVID-19 Rapid Testing Locations Around New York

NEW YORK, Feb. 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19 rapid testing around New York. This program is designed to provide New Yorkers, and those visiting, with inexpensive and rapid COVID-19 testing.